Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study.
Makuza JD, Jeong D, Binka M, Adu PA, Cua G, Yu A, Velásquez García HA, Alvarez M, Wong S, Bartlett S, Karim ME, Yoshida EM, Ramji A, Krajden M, Janjua NZ. Makuza JD, et al. Among authors: adu pa. Viruses. 2022 Nov 21;14(11):2579. doi: 10.3390/v14112579. Viruses. 2022. PMID: 36423186 Free PMC article.
Chronic hepatitis C infection is associated with higher incidence of extrahepatic cancers in a Canadian population based cohort.
Darvishian M, Tang T, Wong S, Binka M, Yu A, Alvarez M, Alexander Velásquez García H, Adu PA, Jeong D, Bartlett S, Karamouzian M, Damascene Makuza J, Wong J, Ramji A, Woods R, Krajden M, Janjua N, Bhatti P. Darvishian M, et al. Among authors: adu pa. Front Oncol. 2022 Oct 13;12:983238. doi: 10.3389/fonc.2022.983238. eCollection 2022. Front Oncol. 2022. PMID: 36313680 Free PMC article.
Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations.
Rossi C, Jeong D, Wong S, McKee G, Butt ZA, Buxton J, Wong J, Darvishian M, Bartlett S, Samji H, Yu A, Binka M, Alvarez M, Adu PA, Tyndall M, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort Team. Rossi C, et al. Among authors: adu pa. J Hepatol. 2019 Dec;71(6):1116-1125. doi: 10.1016/j.jhep.2019.07.021. Epub 2019 Aug 6. J Hepatol. 2019. PMID: 31433302
Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia.
Jeong D, Karim ME, Wong S, Wilton J, Butt ZA, Binka M, Adu PA, Bartlett S, Pearce M, Clementi E, Yu A, Alvarez M, Samji H, Velásquez García HA, Abdia Y, Krajden M, Janjua NZ. Jeong D, et al. Among authors: adu pa. BMJ Open Diabetes Res Care. 2021 Jun;9(1):e002145. doi: 10.1136/bmjdrc-2021-002145. BMJ Open Diabetes Res Care. 2021. PMID: 34099439 Free PMC article.
Treatment of HCV with direct-acting antivirals on reducing mortality related to extrahepatic manifestations: a large population-based study in British Columbia, Canada.
Jeong D, Wong S, Karim ME, Manges AR, Makuza JD, Bartlett SR, Velásquez García HA, Luster D, Adu PA, Binka M, Yu A, Krajden M, Janjua NZ. Jeong D, et al. Among authors: adu pa. Lancet Reg Health Am. 2023 Dec 29;29:100658. doi: 10.1016/j.lana.2023.100658. eCollection 2024 Jan. Lancet Reg Health Am. 2023. PMID: 38235369 Free PMC article.